purchase customization

1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid Drugs Overall Market Size
2.1 Global Nucleic Acid Drugs Market Size: 2023 VS 2032
2.2 Global Nucleic Acid Drugs Market Size, Prospects & Forecasts: 2023-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Nucleic Acid Drugs Players in Global Market
3.2 Global Companies Nucleic Acid Drugs Product & Technology
4 Nucleic Acid Drugs Companies Profiles
4.1 Sarepta Therapeutics
4.1.1 Sarepta Therapeutics Company Summary
4.1.2 Sarepta Therapeutics Business Overview
4.1.3 Sarepta Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.1.4 Sarepta Therapeutics Nucleic Acid Drugs R&D, and Plans
4.2 Ionis Pharmaceuticals
4.2.1 Ionis Pharmaceuticals Company Summary
4.2.2 Ionis Pharmaceuticals Business Overview
4.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offerings & Technology
4.2.4 Ionis Pharmaceuticals Nucleic Acid Drugs R&D, and Plans
4.3 Alnylam
4.3.1 Alnylam Company Summary
4.3.2 Alnylam Business Overview
4.3.3 Alnylam Nucleic Acid Drugs Product Offerings & Technology
4.3.4 Alnylam Nucleic Acid Drugs R&D, and Plans
4.4 Mina Therapeutics
4.4.1 Mina Therapeutics Company Summary
4.4.2 Mina Therapeutics Business Overview
4.4.3 Mina Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.4.4 Mina Therapeutics Nucleic Acid Drugs R&D, and Plans
4.5 BioNTech
4.5.1 BioNTech Company Summary
4.5.2 BioNTech Business Overview
4.5.3 BioNTech Nucleic Acid Drugs Product Offerings & Technology
4.5.4 BioNTech Nucleic Acid Drugs R&D, and Plans
4.6 NeXstar Pharmaceuticals
4.6.1 NeXstar Pharmaceuticals Company Summary
4.6.2 NeXstar Pharmaceuticals Business Overview
4.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offerings & Technology
4.6.4 NeXstar Pharmaceuticals Nucleic Acid Drugs R&D, and Plans
4.7 Nippon Shinyaku
4.7.1 Nippon Shinyaku Company Summary
4.7.2 Nippon Shinyaku Business Overview
4.7.3 Nippon Shinyaku Nucleic Acid Drugs Product Offerings & Technology
4.7.4 Nippon Shinyaku Nucleic Acid Drugs R&D, and Plans
4.8 Moderna Therapeutics
4.8.1 Moderna Therapeutics Company Summary
4.8.2 Moderna Therapeutics Business Overview
4.8.3 Moderna Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.8.4 Moderna Therapeutics Nucleic Acid Drugs R&D, and Plans
4.9 CureVac
4.9.1 CureVac Company Summary
4.9.2 CureVac Business Overview
4.9.3 CureVac Nucleic Acid Drugs Product Offerings & Technology
4.9.4 CureVac Nucleic Acid Drugs R&D, and Plans
4.10 Regulus Therapeutics
4.10.1 Regulus Therapeutics Company Summary
4.10.2 Regulus Therapeutics Business Overview
4.10.3 Regulus Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.10.4 Regulus Therapeutics Nucleic Acid Drugs R&D, and Plans
4.11 Miragen Therapeutics
4.11.1 Miragen Therapeutics Company Summary
4.11.2 Miragen Therapeutics Business Overview
4.11.3 Miragen Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.11.4 Miragen Therapeutics Nucleic Acid Drugs R&D, and Plans
5 Sights by Region
5.1 By Region - Global Nucleic Acid Drugs Market Size, 2024 & 2032
5.2 By Region - Global Nucleic Acid Drugs Revenue, (2024-2032)
5.3 United States
5.3.1 Key Players of Nucleic Acid Drugs in United States
5.3.2 United States Nucleic Acid Drugs Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Nucleic Acid Drugs in Europe
5.4.2 Europe Nucleic Acid Drugs Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Nucleic Acid Drugs in China
5.5.2 China Nucleic Acid Drugs Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Nucleic Acid Drugs Market Size Markets, 2024 & 2032
6.2 Antisense Nucleic Acid Drugs
6.3 siRNA Drugs
6.4 saRNA Drugs
6.5 miRNA Drugs
6.6 mRNA Drugs
6.7 other
7 Sights by Application
7.1 By Application - Global Nucleic Acid Drugs Market Size, 2024 & 2032
7.2 Genetic Disease
7.3 Cancer
7.4 Cardiovascular Diseases
7.5 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer